Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Chromogenix APC test

This article was originally published in Clinica

Executive Summary

The FDA has cleared Chromogenix' APC resistance test, Coatest, for sale in the US. APC resistance, an inability to shut down coagulation, is inherited in nine out of 10 cases and is also associated with ageing. The Molndal, Sweden-based company has been selling the test in Europe since 1993 where it is one of the company's main products. Chromogenix was granted a US patent for the test technique in August.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093338

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel